Thomas J. Garrity, Director at ANTARES PHARMA, INC. (ATRS), bought 30,000 shares at $0.72 ($22K) on 2016-03-18, disclosed to the SEC on 2016-03-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ATRS | SELL | 2021-01-13 | $284K | — | Filing → |
| ATRS | SELL | 2019-12-11 | $183K | — | Filing → |
| ATRS | SELL | 2019-05-03 | $80K | — | Filing → |